Cbio A/S

Cbio A/S is a biopharmaceutical company developing next generation T-cell therapies against solid tumors. We are soon to enter our First-in-Human clinical study at Karolinska Hospital in Sweden with our proprietary T-cell product, novoleucel, where the T-cell are armed against oxidative stress. We a... Read more